Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Profit After Tax (2013 - 2026)

Biovie (BIVI) posted Profit After Tax of -$5.3 million for Q1 2026, up 13.17% sequentially from -$6.1 million in Q4 2025, and down 89.01% YoY from -$47.9 million in Q1 2025.

Biovie (BIVI) Profit After Tax (2013 - 2026) Analysis & Trends

Biovie has reported Profit After Tax for 13 years, with the latest figure at -$5.3 million in Q1 2026.

  • Quarterly Profit After Tax fell 89.01% year-over-year to -$5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.9 million (down 11.07% YoY) and the FY2025 annual result came in at -$17.5 million, up 45.39% from the prior year.
  • Profit After Tax climbed to -$5.3 million in Q1 2026 per BIVI's latest filing, from -$6.1 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$2.8 million in Q1 2025 and troughed at -$18.0 million in Q3 2022.
  • A 5-year average of -$8.2 million and a median of -$7.1 million in 2024 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 93.85% in 2022, down 224.79% in 2022.
  • Over 5 years, Profit After Tax stood at -$15.7 million in 2022, then soared by 46.44% to -$8.4 million in 2023, then increased by 15.34% to -$7.1 million in 2024, then gained by 14.67% to -$6.1 million in 2025, then gained by 13.17% to -$5.3 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$5.3 million, -$6.1 million, and -$5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Biovie 14.17 Mn 14.17 Mn - -5.65 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.65 Mn
Mar 31, 2026 -5.27 Mn
Dec 31, 2025 -6.07 Mn
Sep 30, 2025 -5.09 Mn
Jun 30, 2025 -3.49 Mn
Mar 31, 2025 -2.79 Mn
Dec 31, 2024 -7.11 Mn
Sep 30, 2024 -4.15 Mn
Jun 30, 2024 -3.88 Mn
Mar 31, 2024 -8.95 Mn
Dec 31, 2023 -8.40 Mn
Sep 30, 2023 -10.89 Mn
Jun 30, 2023 -9.13 Mn
Mar 31, 2023 -15.04 Mn
Dec 31, 2022 -15.69 Mn
Sep 30, 2022 -18.00 Mn
Jun 30, 2022 -8.09 Mn
Mar 31, 2022 -7.04 Mn
Dec 31, 2021 -5.41 Mn
Sep 30, 2021 -5.54 Mn